Archive: Aducanumab
-
New Developments in Alzheimer’s Disease Therapeutics
R. Scott Turner, PhD, MD Memory Disorders Program, MedStar Georgetown University Hospital Nov. 18, 2021 Aducanumab (Aduhelm®) On June 7, 2021 the FDA granted accelerated approval of the anti
Categories: Aducanumab, New developments, News
-
Alzheimer’s Association On Demand Webinars
View some free, on demand webinars regarding a variety of Alzheimer's topics including Aducanmunab on the Alzheimer's Association website. View Here https://www.alz.org/research/for_researcher
Categories: Aducanumab, Events, News